| Recruiting | A Novel Fluorescent Ductal Needle for Localization and Sampling of Micro Lesions in Breast Ducts NCT07339306 | The Fourth Affiliated Hospital of China Medical University | N/A |
| Recruiting | Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction NCT06195306 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | A Patient Navigation Program for Addressing Disparities in Breast Cancer Care NCT06350500 | Roswell Park Cancer Institute | N/A |
| Terminated | Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VEN NCT06617455 | University of Michigan Rogel Cancer Center | Phase 2 |
| Recruiting | Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial NCT06184750 | National Cancer Institute (NCI) | Phase 2 |
| Suspended | High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breas NCT06538389 | City of Hope Medical Center | Phase 2 |
| Recruiting | Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk f NCT05941520 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Metformin and Nightly Fasting in Women With Early Breast Cancer NCT05023967 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast NCT05545150 | Northwestern University | Phase 2 |
| Recruiting | Neoadjuvant Breast Cancer Time Restricted Eating NCT05327608 | Thomas Jefferson University | N/A |
| Active Not Recruiting | Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast NCT05340673 | City of Hope Medical Center | Phase 1 |
| Completed | An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors NCT05012176 | Ohio State University Comprehensive Cancer Center | N/A |
| Recruiting | Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer NCT04959474 | Thomas Jefferson University | N/A |
| Completed | EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer NCT05086705 | Ohio State University Comprehensive Cancer Center | N/A |
| Recruiting | Identifying and Caring for Individuals With Inherited Cancer Syndrome NCT04494945 | OHSU Knight Cancer Institute | N/A |
| Terminated | Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Ca NCT03979508 | Mayo Clinic | Phase 2 |
| Completed | Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer NCT04022772 | M.D. Anderson Cancer Center | N/A |
| Recruiting | A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ NCT04144023 | Mayo Clinic | Phase 1 |
| Recruiting | Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cance NCT04169542 | M.D. Anderson Cancer Center | — |
| Unknown | Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinom NCT04046159 | National Taiwan University Hospital | Phase 3 |
| Active Not Recruiting | Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery NCT03317405 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer NCT03323658 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer NCT02876640 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer NCT02636582 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients Wit NCT01272037 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergo NCT00769379 | National Cancer Institute (NCI) | Phase 3 |